Prostate Cancer Utilities and Cost-Effectiveness Analysis

NCT00203918 | Completed

• 1 other identifier: 12843B
• Study Type: observational
• Target: 481
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of this study is to help doctors and patients make better decisions about prostate cancer treatment. This research is being done because we do not know how patient preferences for health states related to prostate cancer affect the final treatment decision.

Conditions

Prostate Cancer

Keywords

Prostate Cancer; Cost-Effectiveness Analysis; Utility Assessment

Outcome Measures

Primary Outcomes (1)

• Utility scores for treatment outcomes

  Patient utility scores (i.e. patient preference weights) are calculated using survery data will determine which prostate cancer treatment would be most cost-effective for each subject. Patients will be contacted by phone and patient records will be reviewed 90 days after the survey has been completed to determine whether this data reflects actual treatment decisions.

  90 days after enrollment

Secondary Outcomes (1)

• Anxiety levels

  90 days after enrollment

Study Arms (1)

Prostate biopsies

Males undergoing prostate biopsies

Behavioral: Survey, interview; Behavioral: patient utility scores (i.e. patient preference weights)

Interventions

Survey, interview BEHAVIORAL

A survey is administered to patients visiting the urology clinic to undergo prostate biopsies to validate a method of utility assessment, and understand patients' individual evaluations of treatment-related health states. Medical records will also be reviewed 00 days after the survey was administered to determine whether this data reflects actual treatment decisions.

Prostate biopsies

patient utility scores (i.e. patient preference weights) BEHAVIORAL

comparison of patient preferences

Prostate biopsies

Eligibility Criteria

• Age: 18 Years+
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients visiting the urology clinic at the University of Chicago.

You may qualify if:

• Patients undergoing prostate biopsy

You may not qualify if:

• Women and children will be excluded, as prostate cancer occurs in men only
• Diagnosis of dementia

Sponsors & Collaborators

• University of Chicago: lead

Study Sites (1)

The University of Chicago

Chicago, Illinois, 60637, United States

Location

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Surveys and Questionnaires; Interviews as Topic

Condition Hierarchy (Ancestors)

Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Genital Diseases, Male; Genital Diseases; Urogenital Diseases; Prostatic Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• David Meltzer, M.D., Ph.D.

  University of Chicago

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 12, 2005
• First Posted: September 20, 2005
• Study Start: January 1, 2004
• Primary Completion: February 1, 2011
• Study Completion: February 1, 2013
• Last Updated: August 30, 2017

Record last verified: 2017-08

Locations

US (1)